Array BioPharma Inc. (ARRY Quick QuoteARRY - Free Report) was a big mover last session, as the company saw its shares rise over 7% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This continues the recent uptrend of the company, as the stock is now up 24% in the past one-month time frame.

The stock has seen one positive estimate revision in the last 30 days, while the Zacks Consensus Estimate remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Array BioPharma carries a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.

Array BioPharma Inc. Price

 

Array BioPharma Inc. Price | Array BioPharma Inc. Quote

Another favorably placed stock in the same industry is Dicerna Pharmaceuticals, Inc. , sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is ARRY going up? Or down? Predict to see what others think: Up or Down

Zacks' Top Investment Ideas for Long-Term Profit

How would you like to see our best recommendations to help you find today’s most promising long-term stocks? Starting now, you can look inside our portfolios featuring stocks under $10, income stocks, value investments and more. These picks, which have double and triple-digit profit potential, are rarely available to the public. But you can see them now. Click here >>